-
Describing the Real-World Burden of Demodex Blepharitis: A Multicenter Audit in a UK Public Specialist Eye-Care Setting
Sep 9, 2025, 16:22 PM -
Development and Evaluation of a Proactive Monitoring Model for Adverse Drug Events in Patients With Pulmonary Arterial Hypertension Based on the Delphi and Real-World Data
Sep 9, 2025, 16:22 PM -
Implementing Simultaneous Maximum Acceptable Risk Thresholds (SMARTs) in Discrete Choice Experiments (DCE): A Feasible Approach to Quantify Tolerance for Multiple Risks
Sep 9, 2025, 16:22 PM -
From Efficiency to Equity: Considerations in NICE Technology Appraisals
Sep 9, 2025, 16:22 PM -
Population-Level Impact Assessment of the Revised Dyslipidemia Prescription Protocol in Greece Using Simulation Modeling
Sep 9, 2025, 16:22 PM -
Systematic Review of Prognostic Factors and Treatment Effect Modifiers for Transthyretin Amyloid Cardiomyopathy
Sep 9, 2025, 16:22 PM -
Hybrid Digital Support for Patients Receiving Biosimilar-Adalimumab Therapy for Immune-Mediated Inflammatory Disorders: 12-Month Persistence and Impact on Adherence
Sep 9, 2025, 16:22 PM -
A Generalizable Discrete Event Simulation Framework to Assess Clinical and Economic Impact of Prescription Protocol Revisions
Sep 9, 2025, 16:22 PM -
Estimating Rare Disease Incidence and Prevalence of Essential Thrombocythemia in Major Health Plans in the United States
Sep 9, 2025, 16:22 PM -
Burden of Duchenne Muscular Dystrophy in Italy: A Multicenter Cost of Illness Study
Sep 9, 2025, 16:22 PM -
Economic Impact of Lenalidomide-Refractory Multiple Myeloma in Finland: Insights From Real-World Data
Sep 9, 2025, 16:22 PM -
A Retrospective Analysis of Reimbursement Timelines in Ireland: What Does a 10-Year Analysis Show?
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Italy: A Scoping Review
Sep 9, 2025, 16:22 PM -
Transporting Treatment Effects for Survival Outcomes Under Informative Censoring: A Simulation Study Using Summary-Level Data in the Target Population
Sep 9, 2025, 16:22 PM -
Unmet Need in IgA Nephropathy (IgAN): Disparity Between Clinical Guidelines and Real-World Practice in Ireland
Sep 9, 2025, 16:22 PM -
Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis
Sep 9, 2025, 16:22 PM -
Localizing a Sequencing Model Using Patient-Level Data to Optimize Outcomes in the First Line of Treatment for Multiple Myeloma in Greece
Sep 9, 2025, 16:22 PM -
High All-Cause Hospitalization Among Those With Recurrent ASCVD Event: Evidence From a Large-Scale Real-World Database
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM
